Breast cancer

EA1183

FDG PET to Assess Therapeutic Response in Patients with Bone-dominant Metastatic Breast Cancer, FEATURE

Topic

EA1183

Disease

Breast cancer

Description

Primary Objective: Evaluate the performance of FDG-PET/CT response criteria (modified PERCIST complete, partial and stable metabolic disease versus progressive metabolic disease) as a binary predictor of PFS in patients with BD MBC treated with systemic therapy

Contact

Florida
Peggy Mouradian

Physicians

Edgardo Santos

MD

Medical Oncologist

Aventura (Medical oncology)